The weekly litigation news digest is live. Subscribe now

IP Verse

Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use Thereof

Patent No. EP2912175 (titled "Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use Thereof") was filed by Toolgen Incorporated on Oct 23, 2013. The application was issued on Aug 22, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
KELTIEMay 22, 2019MOORE
POHLMANMay 22, 2019POHLMAN
PATENT BOUTIQUEMar 6, 2019PATENT BOUTIQUE
CRISPR THERAPEUTICSSep 14, 2018VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB
GRUNDAug 30, 2018GRUND
SCHLICHAug 22, 2018SCHLICH

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2912175

TOOLGEN INCORPORATED
Application Number
EP13849670A
Filing Date
Oct 23, 2013
Status
Revoked
May 26, 2023
Publication Date
Aug 22, 2018
External Links
Slate, EP2912175B1, Google Patents